Medical/Pharmaceuticals

Identi Medical Wins the Frost & Sullivan Product Innovation Award for Increasing Inventory Visibility in Operating Rooms Using Image Recognition

Identi Medical helps hospitals provide safer care for their patients with its highly differentiated inventory management solutions for operating and procedural rooms SAN ANTONIO, Feb. 23, 2022 /PRNewswire/ -- Based on its recent analysis of the European Operating Room Inventory Management Soluti...

2022-02-23 21:00 2468

Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2022 Financial Results

HONG KONG, Feb. 23, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release its financial result...

2022-02-23 20:00 3026

Sirnaomics Announces Interim Data from Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma

HONG KONG, Feb. 23, 2022 /PRNewswire/ -- Sirnaomics Ltd. ("Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced interim data from a Phase II clinical trial of STP705, a siRNA (small interfering RNA) therapeutic, ...

2022-02-23 17:53 3897

Simcere Pharma (2096.HK) Announces a Positive Profit Alert

HONG KONG, Feb. 23, 2022 /PRNewswire/ -- Simcere Pharmaceutical Group Limited (the "Company", together with its subsidiaries, the "Group"; stock code: 2096.HK), announces a positive profit alert. Based on a preliminary assessment of the Group's unaudited consolidated management accounts for the ...

2022-02-23 16:22 4102

Citadel Health: Pandemic highlights data revolution urgency

LONDON, Feb. 23, 2022 /PRNewswire/ -- David Wells, the biomedical scientist who spearheaded NHS England's COVID-19 testing response, says the pandemic's scale and impact highlights the urgent need to reshape diagnostics worldwide. Mr Wells led the NHS drive to build a nationwide testing service f...

2022-02-23 14:53 2321

The journey from Good to Great: Camly Academy successfully launched in the U.S market

HO CHI MINH CITY, Vietnam, Feb. 23, 2022 /PRNewswire/ -- Recently, Camly Academy of Camly Group successfully held an event to launch an educational platform in the US market with the topic: "Self-Education for Happiness: Good to Great" onFebruary 22, 2022 to announce action mission towards sustai...

2022-02-23 14:49 3121

Radiaction Opens First EU Radiation Protection Center of Excellence in Collaboration with Mazowiecki Hospital in Ostrołęka, Poland

TEL AVIV, Israel, Feb. 22, 2022 /PRNewswire/ -- Radiaction Medical Ltd . ("Radiaction"), an innovative medical device company focused on radiation protection in the interventional cardiology and electrophysiology sectors, has entered into a new collaboration wi...

2022-02-23 10:00 3221

Havas Health & You Announces Expansion Across APAC, Including Southeast Asia (SEA) Village

SINGAPORE, Feb. 23, 2022 /PRNewswire/ -- In the next decade, APAC will represent 40% of total growth in global health spending, expanding at a rate almost double that of the rest of the world – making both presence and investment in APAC more critical than ever. To help Havas Health & You (HH&Y) ...

2022-02-23 09:00 2463

XACT Robotics® Lauded by Frost & Sullivan for Improving CT-guided Percutaneous Procedures with Its Breakthrough Hands-Free Robotic System

The XACT ACE® Robotic System addresses the limitations of traditional manual methods and other image-guided percutaneous intervention systems. SAN ANTONIO, Feb. 22, 2022 /PRNewswire/ -- Frost & Sullivan recently evaluated the North American percutaneous procedure system industry and, based on it...

2022-02-22 23:00 2612

First Japanese Institution to Utilize SOPHiA GENETICS' Myeloid Plus Solution

BOSTON, LAUSANNE, Switzerland, and HIROSHIMA, Japan, Feb. 22, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), today announced an agreement withHiroshima University, one of the top public universities inHiroshima City, Japan, to support their molecular profiling by next-generation sequencing ...

2022-02-22 20:57 3369

RosVivo Therapeutics, Inc. signed a Material Transfer Agreement (MTA) for first-in-class diabetes treatment with Eli Lilly and Company

SEOUL, South Korea, Feb. 22, 2022 /PRNewswire/ -- RosVivo Therapeutics, Inc. (hereinafter referred to as "RosVivo") announced that it has signed a Material Transfer Agreement (MTA) with one of the largest global pharmaceutical companies Eli Lilly and Company (hereinafter referred to as "Eli Lilly...

2022-02-22 20:52 4839

Gracell Biotechnologies Announces Multiple Advancements of TruUCAR Allogeneic CAR-T Platform

SUZHOU, China, and PALO ALTO, Calif., Feb. 22, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, toda...

2022-02-22 20:30 2808

InnoCare Announces Dosing of First Patient in Phase II Clinical Trial Using Orelabrutinib for the Treatment of ITP

BEIJING, Feb. 22, 2022 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company, announced today that the first patient has been dosed in Phase II clinical trial of its Bruton's tyrosine kinase (BTK) inhibitor orelabrutinib for the treatment of primary immune thrombocyto...

2022-02-22 17:09 2883

4D IMAGING RADAR LEADER VAYYAR EXPANDS GLOBAL FOOTPRINT WITH NEW JAPAN OFFICE

- Vayyar Imaging's new office will open in Tokyo, Japan in February, supporting the technology company's growth strategy in the key senior care and automotive markets - Vayyar's touchless senior care technology is deployed in facilities and private homes around the world, providing activity moni...

2022-02-22 17:00 3892

111 to Announce Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results on March 17, 2022 - Conference Call to Follow

SHANGHAI, Feb. 22, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced that it will report its unaudited financial results...

2022-02-22 16:38 2494

Nippon Express Obtains GDP Certification for Temperature-controlled Facility at Kansai International Airport

TOKYO, Feb. 22, 2022 /PRNewswire/ -- Nippon Express Co., Ltd. (hereinafter "Nippon Express"), a group company of Nippon Express Holdings, Inc., has obtained Good Distribution Practice (GDP) certification, effectiveJanuary 11, for NX-PHARMA Logistics Hub Kansai Airport, a temperature-controlled fa...

2022-02-22 15:00 3846

Nanoform 4Q and full year 2021 report: accelerating GMP growth

HELSINKI, Feb. 22, 2022 /PRNewswire/ -- The strong momentum continues: first two customer GMP projects signed, full-year gross margin exceeds 2025 target, the rapid growth in orders received and revenue recognized accelerates further, the first clear signs of economics of scale emerges, while the...

2022-02-22 14:33 2073

Winner Silver Alginate Dressing has Obtained 510K Code in the USA

SHENZHEN, China, Feb. 21, 2022 /PRNewswire/ -- Recently, the silver alginate dressing of Winner Medical (300888.SZ) receives U.S. FDA market access (510K Number: K202982), marking that this product has obtained the qualification to get into the access US market and Winner Medical will further e...

2022-02-22 10:10 2838

Revotek Receives Clearance from the National Health Commission of China for the World First Clinical Trial for 3D Bioprinted Stem Cell Vascular Grafts

CHENGDU, China, Feb. 21, 2022 /PRNewswire/ -- Revotek announced that it has received clearance from the National Health Commission ofChina to begin a clinical study in the West China Hospital,Chengdu, with its first stem cell 3D bioprinting product, REVOVAS.

2022-02-21 22:30 2306

HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer

SEOUL, South Korea, Feb. 21, 2022 /PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS) announced today the appointment ofAlmira Chabi, M.D. as Chief Medical Officer and Chief Development Officer at HanAll Pharmaceutical International (HPI), a U.S. entity wholly owned by HanAll Biopharma, to strengt...

2022-02-21 22:00 2740
1 ... 597598599600601602603 ... 644